Search by Drug Name or NDC

    NDC 29300-0381-01 divalproex sodium 500 mg/1 Details

    divalproex sodium 500 mg/1

    divalproex sodium is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Unichem Pharmaceuticals (USA), Inc.. The primary component is DIVALPROEX SODIUM.

    Product Information

    NDC 29300-0381
    Product ID 29300-381_9390848b-5ce6-4746-8d27-75367862291e
    Associated GPIs
    GCN Sequence Number 046315
    GCN Sequence Number Description divalproex sodium TAB ER 24H 500 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 18040
    HICL Sequence Number 001884
    HICL Sequence Number Description DIVALPROEX SODIUM
    Brand/Generic Generic
    Proprietary Name divalproex sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name divalproex sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name DIVALPROEX SODIUM
    Labeler Name Unichem Pharmaceuticals (USA), Inc.
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214643
    Listing Certified Through 2024-12-31

    Package

    NDC 29300-0381-01 (29300038101)

    NDC Package Code 29300-381-01
    Billing NDC 29300038101
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (29300-381-01)
    Marketing Start Date 2022-07-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.17771
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DIVALPROEX SOD ER 500 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis